Merck
MRK
#50
Rank
HK$2.368 T
Marketcap
HK$959.00
Share price
5.64%
Change (1 day)
58.91%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): HK$27.70

According to Merck's latest financial reports the company's current EPS (TTM) is HK$27.87. In 2025 the company made an earnings per share (EPS) of HK$57.09 an increase over its 2024 EPS that were of HK$52.95.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.70-51.47%
2025HK$57.097.81%
2024HK$52.954308.46%
2023HK$1.20-97.32%
2022HK$44.8910.92%
2021HK$40.4784.68%
2020HK$21.91-27.2%
2019HK$30.1063.44%
2018HK$18.42151.11%
2017HK$7.33-54.58%
2016HK$16.1530.21%
2015HK$12.40-61.99%
2014HK$32.62180.51%
2013HK$11.63-31.82%
2012HK$17.066.62%
2011HK$16.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.44 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.00 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.27 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.13 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.44 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.05-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.89 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.45 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$10.73-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel